Kneevoice closed its oversubscribed seed round of financing, with a total of $1.25 million raised.
The company is developing medical technology designed to detect cartilage deterioration in the joints, improve patient outcomes and streamline healthcare processes. Kneevoice noninvasively captures the vibrations and position of sounds emanating from the patellofemoral joint and processes them through a proprietary algorithm to produce a score that represents the depth and degradation of the cartilage.
The raised capital will support the finalization of medical trials, pursuit of FDA clearance and commencement of commercial operations.
Kneevoice closed its oversubscribed seed round of financing, with a total of $1.25 million raised.
The company is developing medical technology designed to detect cartilage deterioration in the joints, improve patient outcomes and streamline healthcare processes. Kneevoice noninvasively captures the vibrations and position of sounds emanating...
Kneevoice closed its oversubscribed seed round of financing, with a total of $1.25 million raised.
The company is developing medical technology designed to detect cartilage deterioration in the joints, improve patient outcomes and streamline healthcare processes. Kneevoice noninvasively captures the vibrations and position of sounds emanating from the patellofemoral joint and processes them through a proprietary algorithm to produce a score that represents the depth and degradation of the cartilage.
The raised capital will support the finalization of medical trials, pursuit of FDA clearance and commencement of commercial operations.
Copy to clipboard 
